Porphyria cutanea tarda manifestation in patients infected with human immunodeficiency virus;Manifestación de porfiria cutánea tardía en pacientes infectados con el virus de la inmunodeficiencia humana

Acta Bioquimica Clinica Latinoamericana

Volumn 40, Issue 1, 2006, Pages 29-34

  Melito, Viviana Alicia ^a,b   Parera, Victoria Estela ^a,b   Rossetti, María Victoria ^a,b   Batlle, Alcira ^a,b,c  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c NONE   (Argentina)

Author keywords

Haem biosynthesis; Human immunodeficiency virus; Porphyria cutanea tarda; Porphyrias; Uroporphyrinogen decarboxylase

Indexed keywords

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33747426326     PISSN: 03252957     EISSN: 03252957     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Anderson KE, Sassa S, Bishop DF, Desnick RJ. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. In: Scriver CS, Beaudet AL, Sly WS, Valle D, Editors. The Metabolic and Molecular Basis of Inherited Disease. New York: Mc Graw Hill 2000; pp 2991-3062.
2. Méndez M, Rossetti MV, Batlle A, Parera, V. The role of inherited and acquired factors in the development of Porphyria Cutanea Tarda in the Argentine population. J Am Acad Dermatol 2005; 52: 417-24.
3. Jackson AH, Ferramola AM, Sancovich HA, Evans N, Matlin SA, Ryder DJ et al. Hepta and hexa-carboxylic porphyrinogen intermediates in haem biosynthesis. Ann Clin Res 1976; 8: 64-9.
4. De Verneuil H, Aitken G, Nordmann Y. Familiar and sporadic porphyria cutanea: two different diseases. Hum Genet 1978; 44: 145-51
5. Elder GH, Shepard DM, Enriquez de Salamanca R, Olmos A. Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase. Clin Sci 1980; 58: 477-84.
6. D'Alessandro GL, Grisso D, Macri A, Biolcati G, Topi GC. Familiar porphyria cutanea tarda with normal erythrocytic urodecarboxylase: an exception to the rule? Dermatologica 1989; 178: 206-8.
7. Fargion S, Piperno A, Cappelini M, Sampietro M, Francazani AL, Romano R et al. Hepatitis virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992; 16: 1322-6.
8. Wissel PS, Sordillo P, Anderson, KE, Sassa S, Savillo RL, Kappas K. Porphyria cutanea tarda associated with the acquired immunodeficiency syndrome Am J Hematol 1987; 25: 107-13.
9. Mc Alister F, McClean K, Hamilton P. Human immunodeficiency virus infection and porphyria cutanea tarda: coexistence of risk factors or causative association? Clin Infect Dis 1995; 20: 348-51.
10. Drobacheff C, Derancourt C, Van Landuyt H, Devred D, de Wazier B, Cribier B et al. Porphyria cutanea tarda associated with human immunodeficiency virus infection. Eur J Dermatol 1998; 8: 492-6.
11. Hift RJ, Corrigall, AV, Hancock V, Kannemeyer J, Kirsch RE, Meisner PN. Porphyria Cutanea Tarda: the ethiological importance of mutations in the HFE gene and viral infection is population-dependent. Cell Mol Biol 2002; 48: 853-9.
12. Almehmi A, Deliri H, Szego GG, Teague C, Pfister AK , Martin SA Porphyria Cutanea Tarda in a patient with HIV infection. West Virginia Med J 2005; 10: 19-21.
13. Parera VE, Méndez M, Melito VA, Stella AM, Jaled M, Bermejo A et al. Acerca de diecisiete casos de virus de inmunodeficiencia humana que desarrollaron porfiria cutánea tardía. Datos bioquímicos. Rev Argent Dermatol 1995; 76: 230-5.
14. Batlle AM del C. El laboratorio de las porfirias, en Porfirinas y Porfirias. Aspectos Clínicos, Bioquímicos y Biología Molecular. Actualizaciones médico-bioquímicas. Acta Bioquím Clín Latinoam Supl 3; 1997, pp 145-71.
15. Afonso SG, Chinarro S, Stella AM, Lenczner JM, Batlle AM del C, Magnin PH. Uroporfirinógeno Decarboxilasa eritrocitaria y hepática en Porfiria Cutánea Tardía. Rev Argent Dermatol 1985; 66: 12-23.
16. Batlle AM del C, Stella AM, Melito VA, Guzmán M, Pietropaolo N, Cabrera H. Estudio comparativo de los tratamientos de la Porfiria Cutánea Tardía con S-Adenosil-L-Metionina (SAM) y cloroquina. Flebotomías y cloroquina combinadas y la sola administración de SAM, cloroquina o flebotomía. Rev Argent Dermatol 1988; 69: 245-53.
17. Fargion S, Francazani AL, Romano R, Cappellini MD, Fare M, Mattioli M et al. Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload. J Hepatol 1996; 24: 569-4.
18. Bulaj Z, Phillips J, Ajoka R, Franklin M, Griffen LM, Guinee D et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 2000; 95: 11565-71.
19. Stuart K, Busfield F, Jazwinska E, Gibson P, Butterworth L, Coolskey W et al. The C282Y mutations in the hemocromatosis gene (HFE) and hepatitis C virus infection are independent factors for porphyia cutanea tarda in Australian patients. J Hepatol 1998; 28: 404-9.
20. Sampietro M, Piperno A, Lupica L, Arosio C, Vergani A, Corbetta N et al. High prevalence of the H63D HFE mutation in Italian patients with Porphyria Cutanea Tarda. Hepatology 1998; 37: 181-4.
21. Cruz-Rojo J, Fontanellas A, Morán-Jiménez MJ, Navarro-Ordoñez S, García-Bravo M, Méndez M et al. Precipitating-aggravating factors of porphyria cutanea tarda in Spanish patients. Cell Mol Biol 2002; 48: 845-52.
22. Morán MJ, Fontanellas A, Brudieux E, Hombrados I, de Ledinghem V, Couzigou P et al. Hepatic uroporphyrinogen decarboxylase activity in Porphyria cutanea tarda patients: the influence of virus C infection. Hepatology 1998; 27: 584-9.